News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Paolo Tarantino: More important than ever to perform NGS/ctDNA to select the best 2L treatment after CDK4/6i
Photo taken from Paolo Tarantino/Twitter
Nov 19, 2023, 17:20

Paolo Tarantino: More important than ever to perform NGS/ctDNA to select the best 2L treatment after CDK4/6i

Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter:

“Capivasertib is now approved in combo with fulvestrant for pts with pretreated ER+/HER2- MBC whose tumor has an alteration in PIK3CA, AKT1 or PTEN (approx 40%).

More important than ever to perform NGS/ctDNA to select the best 2L treatment after CDK4/6i.”

For more information click here.
Source: Paolo Tarantino/Twitter

cancer Capivasertib OncoDaily Oncology Paolo Tarantino
Special Coverage
Blog
Apr 24, 2025, 17:56
Milestones from Philippine Cervical Cancer Elimination Operational Plan Workshop - APAC Women's Cancer Coalition
Blog
Apr 24, 2025, 17:55
Julie S. Torode: Attending my first ever AACR conference this week - long over due
Blog
Apr 24, 2025, 17:41
The Ohio State’s James Cancer Hospital and Solove Research Institute Welcomes Dr. Kimryn Rathmell as New CEO
Blog
Apr 24, 2025, 17:36
Bishal Gyawali: WHO EML working group discussion on checkpoint inhibitors for solid cancers
Blog
Apr 24, 2025, 17:27
Shane Jacobson: I had the chance to celebrate Dave Coulier being cancer free and now an Ambassador for the V Foundation
Blog
Apr 24, 2025, 17:27
Vidith Phillips: AI is entering hospitals faster than it’s entering medical training - and that’s a problem
Blog
Apr 24, 2025, 17:25
Sharon Kapambwe reflects on cancer journey of family matriarch and urges better access to care
Blog
Apr 24, 2025, 17:15
Rami Manochakian: Abstracts titles for the 2025 ASCO annual meeting are now available
Blog
Apr 24, 2025, 17:12
Anne Laprie’s leadership in paediatric radiation oncology - SIOP Europe
Blog
Apr 24, 2025, 17:06
Mohamad Mohty: Welcome to ⁦the World Congress on Controversies in Multiple Myeloma
Science
Apr 24, 2025, 16:57
Clinical Impact of SVGs of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced NSCLC
Blog
Apr 24, 2025, 16:56
SIOP 2025 Keynote Sessions to address global challenges and advances in paediatric oncology